Table 4.
Secondary Outcomes: Dosing in the DEX (n = 39) and No-DEX (n = 39) Groups
| DEX | No DEX | p value | |
|---|---|---|---|
| Dosing | |||
| Dexmedetomidine, mcg/kg/hr, mean ± SD | 0.36 ± 0.12 | — | — |
| Morphine, mcg/kg/hr, mean ± SD | 33 ± 18.2 | 26.7 ± 12.3 | 0.13 |
| Fentanyl, mcg/kg/hr, mean (range) | 1.5 | 1 (1–2) | — |
| Duration of infusion, hr, median (IQR) | 91.5 (64.25–135.25) | 67.25 (44.5–170.5) | 0.9 |
| Duration of infusion of other drugs | |||
| Opioids, hr, median (IQR) | 61.5 (37.1875–93.375) | — | — |
| Benzodiazepines, hr, median (IQR) | — | 205.875 (150.688–205.875) | — |
DEX, dexmedetomidine; IQR, interquartile range